About Pricing FAQs Providers Trials Blog

Login Get started

Finding studies

Your health journey, clearly organized.

Questions? [email protected]

Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Privacy Policy
Terms of Service

© 2026 Clareo Health. All rights reserved.

Clareo Health | Psoriasis Clinical Trials in Phoenix | 35 Studies

Clinical Trials PsoriasisPhoenix

Psoriasis Clinical Trials in Phoenix

Find 35 clinical trials for psoriasis near Phoenix, Arizona. Connect with research centers in your area.

All Psoriasis trials nationwide All trials in Phoenix

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4No phase

Who can join

Healthy volunteers too

Showing 1-20 of 35 trials

CompletedA Study Comparing Upadacitinib (ABT-494) to Placebo and to Adalimumab in Participants With Psoriatic Arthritis Who Have an Inadequate Response to at Least One Non-Biologic Disease Modifying Anti-Rheumatic Drug (DMARD)This study includes two periods.NCT03104400·Huntsville, Alabama and 344 others

Psoriasis Trials in Other Cities

New York Los Angeles Chicago Houston Philadelphia San Antonio

Data from ClinicalTrials.govTerms

CompletedA Study of Guselkumab and Golimumab Combination Therapy in Participants With Active Psoriatic ArthritisThe purpose of this study is to evaluate the efficacy of guselkumab plus golimumab combination treatment in participants with active psoriatic arthritis (PsA) and inadequate…NCT05071664·Phoenix, Arizona and 81 others

CompletedEfficacy and Safety of Subcutaneous Abatacept in Adults With Active Psoriatic ArthritisThe purpose of this study is to compare subcutaneous Abatacept to placebo in the treatment of psoriatic arthritisNCT01860976·Phoenix, Arizona and 81 others

CompletedGuselkumab in Active Psoriatic Arthritis Participants With Inadequate Response/Intolerance to One Prior Anti-TNF Alpha AgentThe purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) and inadequate response (IR) and/or intolerance…NCT04936308·Mountain Brook, Alabama and 168 others

WithdrawnStudy to Evaluate the Efficacy and Safety of P-3073 Nail Solution in the Treatment of Mild to Moderate Psoriatic Fingernail/sThe objective of this phase III study is to evaluate the efficacy, systemic safety and local tolerability of P-3073 (calcipotriene 0.005%) nail solution in patients with mild to…NCT03079973·Birmingham, Alabama and 57 others

TerminatedPsoriatic Arthritis Study of IzokibepIzokibep is a potent and selective inhibitor of interleukin (IL)-17A that is being developed for treatment of psoriatic arthritis (PsA).NCT05623345·Flagstaff, Arizona and 70 others

CompletedA Study of Ixekizumab (LY2439821) in Participants With Active Psoriatic ArthritisThe main purpose of this study is to evaluate how effective and safe the study drug known as ixekizumab is in participants with active psoriatic arthritis.NCT02349295·Birmingham, Alabama and 108 others

CompletedLong-Term Extension Trial of Tildrakizumab to Prove Its Safety in Subjects With Psoriatic Arthritis Who Have Previously Completed Study With Tildrakizumab.A long term study to demonstrate the safety of Tildrakizumab in Subjects with Psoriatic Arthritis who Have Previously Completed Study with TildrakizumabNCT03552276·Glendale, Arizona and 65 others

CompletedPhase 3b Safety and Efficacy Study of Apremilast to Treat Moderate to Severe Plaque-plaque PsoriasisThis study will test the clinical effectiveness and safety of apremilast compared with placebo as well as etanercept compared with placebo in the same group of patients with…NCT01690299·Phoenix, Arizona and 81 others

RecruitingObservational Study of Pediatric Rheumatic Diseases: The CARRA RegistryContinuation of the CARRA Registry as described in the protocol will support data collection on patients with pediatric-onset rheumatic diseases.NCT02418442·Birmingham, Alabama and 81 others

CompletedA Study to Test the Efficacy and Safety of Bimekizumab in the Treatment of Subjects With Active Psoriatic ArthritisThis is a study to demonstrate the clinical efficacy, safety and tolerability of bimekizumab administered subcutaneously (sc) compared with placebo in the treatment of subjects…NCT03895203·Phoenix, Arizona and 135 others

CompletedEfficacy and Safety Study of Apremilast to Treat Active Psoriatic ArthritisThe purpose of this study is to determine whether apremilast is safe and effective in the treatment of patients with psoriatic arthritis, specifically in improving signs and…NCT01172938·Birmingham, Alabama and 91 others

CompletedIxekizumab Concomitantly Administered With Tirzepatide in Adults With Psoriatic Arthritis and Obesity or OverweightThe main purpose of this study is to demonstrate that when participants with psoriatic arthritis and obesity or overweight in the presence of at least 1 weight-related comorbid…NCT06588296·Avondale, Arizona and 85 others

Active not recruitingPsoriasis Longitudinal Assessment and RegistryThe purpose of this study is to further evaluate the safety of infliximab, ustekinumab, and guselkumab in patients with plaque and other forms of psoriasis.NCT00508547·Birmingham, Alabama and 319 others

Active not recruitingA Study to Investigate Effectiveness of Tirzepatide Following Initiation of Ixekizumab in Participants With Active Psoriatic Arthritis and Overweight or Obesity in Clinical Practice (TOGETHER AMPLIFY-PsA)The main purpose of this study is to assess the effectiveness of adding tirzepatide to ixekizumab therapy in standard clinical practice in participants with active PsA and obesity…NCT06864026·Avondale, Arizona and 54 others

Active not recruitingA Study of Guselkumab Administered Subcutaneously in Bio-naive Participants With Active Psoriatic Arthritis Axial DiseaseThe purpose of this study is to evaluate the efficacy of guselkumab treatment in participants with active psoriatic arthritis (PsA) axial disease by assessing reduction in axial…NCT04929210·Avondale, Arizona and 241 others

CompletedEfficacy and Safety of Subcutaneous Secukinumab for Moderate to Severe Chronic Plaque-type Psoriasis for up to 1 YearThis study will assess the safety and efficacy of secukinumab compared to placebo in patients that have moderate to severe, chronic, plaque-type psoriasis.NCT01365455·Birmingham, Alabama and 87 others

RecruitingA Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have Not Taken Biologic MedicinesPsoriatic arthritis (PsA) is a chronic inflammatory disease that affects the joints and skin in people who have psoriasis (PsO).NCT06671483·Chandler, Arizona and 187 others

Active not recruitingEvaluation of Sonelokimab in Patients With Active Psoriatic Arthritis and Anti-TNFα Inadequate ResponseThis is a study to confirm the clinical efficacy and safety of sonelokimab compared with placebo in the treatment of adults with active psoriatic arthritis who have had a previous…NCT06641089·Avondale, Arizona and 142 others

Active not recruitingLong Term Evaluation of Safety and Efficacy of Tildrakizumab in Patients With Psoriatic ArthritisAn open label phase 3 studyNCT04991116·Dothan, Alabama and 98 others

Page 1 of 2Next

Other Conditions in Phoenix

Breast Cancer Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia